A P-glycoprotein- and MRP1-independent Doxorubicin-resistant Variant of the MCF-7 Breast Cancer Cell Line with Defects in Caspase-6, -7, -8, -9 and -10 Activation Pathways

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 123-131

  Park, Soo Jung ^a   Wu, Ching Haung ^a   Safa, Ahmad R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspases; Cytochrome c; Death receptors; Leukemia; Mitochondria; Taxol

Indexed keywords

CASPASE; CASPASE 10; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; DOXORUBICIN; GLYCOPROTEIN P; LIPOCORTIN 5; MESSENGER RNA; METHYLENE BLUE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; BINDING ASSAY; CANCER CELL CULTURE; CELL ASSAY; CELL GROWTH; CELL STRAIN MCF 7; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; HUMANS; ISOENZYMES; P-GLYCOPROTEIN; RNA, MESSENGER;

EID: 1442326136     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Tew KD: Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54: 4313-4320, 1994.
2. Safa AR: Multidrug resistance. In: Principles of Antineoplastic Drug Development and Pharmacology (Schilsky RL, Ratain MJ and Milano GA, eds) New York, Marcel Dekker Inc. 1996, pp 457-486.
3. Konstantinidou AE, Korkolopoulou P and Patsouris E: Apoptotic markers for tumor recurrence. Apoptosis 7: 461-470, 2002.
4. Ivanov VN, Bhoumik A and Ronai Z: Death receptors and melanoma resistance to apoptosis. Oncogene 22: 3152-3161, 2003.
5. Litman T, Druley TE, Stein WD and Bates SE: From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58: 931-959, 2001.
6. Bergman AM, Pinedo HM and Peters GJ: Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine). Drug Resist Updat 5: 19-33, 2002.
7. Hong X, Lei L and Glas R: Tumors acquire inhibitor of apoptosis protein (IAP) mediated apoptosis resistance through altered specificity of cytosolic proteolysis. Exp Med 197: 1731-1743, 2003.
8. Ogretmen B and Safa AR: Identification and characterization of the MDR1 promoter enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line. Biochemistry 39: 194-204, 2000.
9. Dimanche-Boitrel MT, Pelletier H, Genne P, Petit JM, Le Grimellec C, Canal P, Ardiet C, Bastian G and Chauffert B: Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. Int J Cancer 50: 677-682, 1992.
10. 2-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. Oncogene 20: 7006-7020, 2001.
11. Kunstle G, Leist M, Uhlig S, Revesz L, Feifel R, MacKenzie A and Wendel A: ICE protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 55: 5-10, 1997.
12. Rodriguez I, Matsuura K, Ody C, Nagata S and Vassalli P: Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184: 2067-2072, 1996.
13. Earnshaw WC, Martins LM and Kaufmann SH: Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem. 68: 383-424, 1999.
14. Kolenko VM, Uzzo RG, Bukowski R and Finke JH: Caspase-dependent and independent death pathways in cancer therapy. Apoptosis 5: 17-20, 2000.
15. Debatin KM, Poncet D and Kroemer G: Chemotherapy Targeting the mitochondrial cell death pathway. Oncogene 21: 8786-8803, 2002.
16. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H and Toge T: Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 50: 343-352, 2002.
17. Sartorius U, Schmitz I and Krammer PH: Molecular mechanisms of death-receptor mediated apoptosis. Chembiochem 2: 20-29, 2001.
18. Ferri KF, Jacotot E, Blanco J, Este JA, Zamzami N, Susin SA Xie Z Brothers G Reed JC Penninger JM and Kroemer G: Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med 192: 1081-1092, 2000.
19. Li H, Zhu H, Xu CJ and Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
20. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR and Martin SJ: Ordering the cytochrome c initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8 and -10 in a caspase-9-dependent manner. J Cell Biol 144: 281-292, 1999.
21. Slee EA, Adrian C and Martin SJ: Executioner caspase-3, -6 and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis J Biol Chem 276: 7320-7326, 2001.
22. Wolf BB and Green DR: Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274: 20049-20052, 1999.
23. Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996.
24. Janicke RU, Sprengart ML, Wati MR and Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998.
25. de Almodovar CR, Ruiz-Ruiz C, Munoz-Pinedo C, Robledo G and Lopez-Rivas A: The differential sensitivity of Bcl-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bcl-2 protein levels. Oncogene 20: 7128-7133, 2001.
26. Janicke RU, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K and Porter AG: Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene 20: 5043-5053, 2001.
27. Cuvillier O, Nava VE, Murthy SK, Edsall LC, Levade T, Milstien S and Spiegel S: Sphingosine generation, cytochrome c release and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ 8: 162-171, 2001.
28. Wolf BB, Schuler M, Li W Eggers-Sedlet B Lee W, Tailor P, Fitzgerald P, Mills GB and Green DR: Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 276: 34244-34251, 2001.
29. Chen JS, Agarwal N and Mehta K: Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res Treat 71: 237-247, 2002.
30. Notarbartolo M, Cervello M, Dusonchet L, Cusimano A and D'Alessandro N: Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett 180: 91-101, 2002.
31. Matta H, Eby MT, Gazdar AF and Chaudhary PM: Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosis. Cancer Biol Ther 1: 652-660, 2002.
32. Yang Y, Fang S, Jensen JP, Weissman AM and Ashwell JD: Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288: 874-877, 2000.
33. Yang YL and Li XM: The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10: 169-177, 2000.
34. Luque LE, Grape KP and Junker M: A highly conserved arginine is critical for the functional folding of inhibitor of apoptosis (IAP) BIR domains. Biochemistry 41: 13663-13671, 2000.
35. Ng CP and Bonavida B: X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP binding protein with low pl (Smac/DIABLO). Mol Cancer Ther 1: 1051-1058, 2002.
36. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen and GS Reed JC: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17: 2215-2223, 1998.
37. Rebbaa A, Zheng X, Chou PM and Mirkin BL: Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22: 2805-2811, 2003.
38. Chang BD, Swift ME, Shen M, Fang J, Broude EV and Roninson IB: Molecular determinants of terminal growth arrest induced in tumor cells by chemotherapeutic agent. Proc Natl Acad Sci USA 99: 389-394, 2002.
39. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P and Wyche JH: Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 277: 17154-17160, 2002.
40. Li Y, Dowbenko D and Lasky LA: AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277: 11352-11361, 2002.
41. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH and Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3: 245-252, 2001.
42. Fan Y, Borowsky AD and Weiss RH: An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol Cancer Ther 2: 773-782, 2003.